@article{MAKHILLRJMS202014212220,
    title = {The Rate of Migraine Headache among Sample of Iraqi Diabetic Patients: A Cross Sectional
Study},
    journal = {Research Journal of Medical Sciences},
    volume = {14},
    number = {2},
    pages = {34-38},
    year = {2020},
    issn = {1815-9346},
    doi = {rjmsci.2020.34.38},
    url = {https://makhillpublications.co/view-article.php?issn=1815-9346&doi=rjmsci.2020.34.38},
    author = {Hussein},
    keywords = {population,Significant,Iraq,migraine headache,Diabetes mellitus,insulin therapy Corresponding},
    abstract = {Migraine is characterized by recurrent attacks
of headache and its pathophysiology is still enigmatic. A
number of environmental factors has been suggested to
play a role in the pathogenesis of migraine by some
authors. Trials of linking metabolic derangements to the
pathophysiology of headache episode in migraine patients
have recently emerged in a number of literatures. Obesity
and diabetes have been evaluated in a number of studies
in relation to migraine. To evaluate the rate of migraine
headache among a sample of Iraqi diabetic patients.
Current cross sectional study included 200 patients
already diagnosed as having type 1 or 2 diabetes mellitus.
Those patients were reviewed for having criteria
suggesting migraine headache according to “International
Classification of Headache Disorders (ICHD)	”. Variables
included in the present study are: age, gender, type of
diabetes mellitus, duration of diabetes and the level of
HbA1c%. The study was conducted at the neurology
unit, Al-Dewaniyah Teaching Hospital, Al-Dewaniyah
province, Iraq. The study started on January, 2017 and
ended at June, 2018. Number of diabetic patients with
migraine was 58 out of 200 accounting for a rate of 29%.
Migraineurs were more likely to be female gender in
comparison with diabetic non-migraineurs, male to female
proportion of 21/37 versus 79/63, respectively; the
difference was significant (p = 0.013). Patients with type
1 diabetes were more liable to have migraine than patients
with type 2 diabetes, 13 out of 29 (44.8%) versus 45 out
of 171 (26.3%), respectively; the difference was
significant (p = 0.042). According to the type of
treatment, those patients on insulin therapy were more
liable to be migraineurs than those patients on oral
hypoglycemic agents, 38 out of 100 (38%) versus 20 out
of 100 (20%), respectively, the difference was highly
significant (p = 0.005). Patients with migraine had
significantly longer duration of diabetes in comparison
with those diabetics who are free of migraine, 7.18±4.43}
    }